Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TMP-301 by Tempero Bio for Amyotrophic Lateral Sclerosis: Likelihood of Approval
TMP-301 is under clinical development by Tempero Bio and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...
TMP-301 by Tempero Bio for Dystonia: Likelihood of Approval
TMP-301 is under clinical development by Tempero Bio and currently in Phase I for Dystonia. According to GlobalData, Phase I...
TMP-301 by Tempero Bio for Substance (Drug) Abuse: Likelihood of Approval
TMP-301 is under clinical development by Tempero Bio and currently in Phase I for Substance (Drug) Abuse. According to GlobalData,...
TMP-301 by Tempero Bio for Anxiety Disorders: Likelihood of Approval
TMP-301 is under clinical development by Tempero Bio and currently in Phase I for Anxiety Disorders. According to GlobalData, Phase...
TMP-301 by Tempero Bio for Alcohol Dependence: Likelihood of Approval
TMP-301 is under clinical development by Tempero Bio and currently in Phase I for Alcohol Dependence. According to GlobalData, Phase...